Scale - Logo.png
Scale Announces $18 Million in Series B Funding Led by Index Ventures, with Accel and YC Joining the Round
August 07, 2018 09:06 ET | Scale
SAN FRANCISCO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Scale today announced that it has raised $18 million in Series B funding, led by Index Ventures with participation from existing investors Accel and...
logo.jpg
Cambridge Innovation Capital leads $10 million Series B funding in SWIM.AI
July 18, 2018 07:04 ET | Cambridge Innovation Capital plc
Cambridge Innovation Capital leads $10 million Series B funding in SWIM.AI Funding will fuel growth in this US-based edge computing business to launch an R&D centre in Cambridge, UK and...
logo.jpg
iTeos Therapeutics Completes $75 Million Series B Financing
June 20, 2018 07:00 ET | iTeos Therapeutics SA
iTeos Therapeutics Completes $75 Million Series B Financing   Oversubscribed financing round led by new U.S. investor MPM Capital  Proceeds to support accelerated development of innovative...
iTeos Therapeutics C
iTeos Therapeutics Completes $75 Million Series B Financing
June 20, 2018 01:00 ET | iTeos Therapeutics SA
iTeos Therapeutics Completes $75 Million Series B Financing   Oversubscribed financing round led by new U.S. investor MPM Capital  Proceeds to support accelerated development of innovative...
Claroty Logo.png
Siemens Selects Claroty as Strategic Partner for Advanced Anomaly Detection and Invests in the Company
June 12, 2018 10:00 ET | Claroty
NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- Claroty, the leader in cybersecurity for industrial control networks, and Siemens, a global technology powerhouse focusing on the areas of...
Claroty Logo.png
Siemens choisit Claroty en tant que partenaire stratégique pour la détection avancée d’anomalies et investit dans l’entreprise
June 12, 2018 10:00 ET | Claroty
NEW YORK, 12 juin 2018 (GLOBE NEWSWIRE) -- Claroty, acteur majeur dans la sécurité des réseaux industriels (OT), et Siemens, un acteur mondial majeur de technologies dans les domaines de...
TRiCares Closes €22
TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimally Invasive Treatment of Tricuspid Regurgitation
June 04, 2018 02:00 ET | TRiCares SAS
TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimally Invasive Treatment of Tricuspid Regurgitation Paris, France and Munich, Germany, June 4, 2018 -...
TRiCares schließt ei
TRiCares schließt eine Finanzierungsrunde der Serie B in Höhe von € 22 Millionen ($ 25,4 Millionen) zur Investition in die Entwicklung einer minimal invasiven Behandlung von Trikuspidal-Insuffizienz
June 04, 2018 02:00 ET | TRiCares SAS
TRiCares schließt eine Finanzierungsrunde der Serie B in Höhe von € 22 Millionen ($ 25,4 Millionen) zur Investition in die Entwicklung einer minimal invasiven Behandlung von Trikuspidal-Insuffizienz ...
TRiCares réalise une
TRiCares réalise une Série B de €22 Millions ($25.4 Millions) pour le développement de son traitement mini-invasif de la régurgitation tricuspide
June 04, 2018 02:00 ET | TRiCares SAS
TRiCares réalise une Série B de €22 Millions ($25.4 Millions) pour le développement de son traitement mini-invasif de la régurgitation tricuspide Paris (France) et Munich (Allemagne), 4 juin 2018 -...
CMR Surgical raises $100 million in a Series B financing
June 04, 2018 02:00 ET | Consilium Strategic Communications
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical raises $100 million in a Series B financing Europe’s largest medical device financing paves way to Versius® commercialisation ...